The Enterprise Value as of December 2025 (TTM) for Calliditas Therapeutics AB (publ) (CLTEF) is 11.24B

According to Calliditas Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 11.24B. This represents a change of 52.33% compared to the average of 7.38B of the last 4 quarters.

Calliditas Therapeutics AB (publ) (CLTEF) Historical Enterprise Value (quarterly & annually)

How has CLTEF Enterprise Value performed in the past?

The mean historical Enterprise Value of Calliditas Therapeutics AB (publ) over the last ten years is 3.83B. The current 11.24B Enterprise Value has changed 29.26% with respect to the historical average. Over the past ten years (40 quarters), CLTEF's Enterprise Value was at its highest in in the June 2024 quarter at 11.26B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Calliditas Therapeutics AB (publ) (CLTEF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Calliditas Therapeutics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Calliditas Therapeutics AB (publ) (CLTEF) Average Enterprise Value

How has CLTEF Enterprise Value performed in the past?

The current Enterprise Value of Calliditas Therapeutics AB (publ) (CLTEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Calliditas Therapeutics AB (publ) (CLTEF) Enterprise Value vs. Peers

How is CLTEF’s Enterprise Value compared to its peers?

Calliditas Therapeutics AB (publ)’s Enterprise Value is greater than Helix BioPharma Corp. (178.01M), greater than Vicapsys Life Sciences, Inc. (49.13M), greater than Relief Therapeutics Holding AG (24.05M), greater than ZIVO Bioscience, Inc. (39.26M), greater than PsyBio Therapeutics Corp. (135.91K), greater than Relief Therapeutics Holding AG (24.05M), greater than Nicox S.A. (31.96M), greater than Alterity Therapeutics Limited (48.31M), greater than Amplia Therapeutics Limited (53.28M), greater than Actinogen Medical Limited (168.15M),

Build a custom stock screener for Calliditas Therapeutics AB (publ) (CLTEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calliditas Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Calliditas Therapeutics AB (publ) (CLTEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Calliditas Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.